Diagnosis of polymorphisms in carcinogen-activating and inactivating enzymes and cancer susceptibility--a review
- PMID: 7607565
- DOI: 10.1016/0378-1119(94)00448-2
Diagnosis of polymorphisms in carcinogen-activating and inactivating enzymes and cancer susceptibility--a review
Abstract
Up to 90% of all cancers are possibly caused by environmental factors, such as tobacco smoke, diet and occupational exposures. The majority of chemical carcinogens require metabolic activation before they interact with cellular macromolecules and can cause cancer initiation. The xenobiotic-metabolising machinery contains two main types of enzymes: the phase-I cytochromes P-450 (CYP) mediating oxidative metabolism, and phase-II conjugating enzymes. Several phase-I and phase-II genes have recently been cloned and identified in humans. Many of them show polymorphism and have been suggested to contribute to individual cancer susceptibility as genetic modifiers of cancer risk. Altered phenotypes and genotypes in the CYP subfamilies CYP1A1, CYP2D6 and CYP2E1 have been associated with tobacco smoke-induced lung cancer and other cancers. Defective glutathione S-transferase (GST) and N-acetyltransferase (NAT) enzymes have been associated with an increased risk of developing lung and bladder cancer. There are also several studies in each category in which no associations have been found. The risk of developing lung cancer is dramatically (up to 40-fold) elevated in subpopulations having simultaneously high-risk genotypes in CYP1A1 and GSTM1. There are several difficulties in this area of research. First, many of the observed restriction-fragment length polymorphisms (RFLPs) are due to mutations in introns or other silent areas of DNA, raising the possibility that any associations found between RFLPs and cancer occur only by chance. Second, biologically plausible mechanisms linking genotypes and cancer are lacking in most of the observed cases.(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
-
[Genetic and phenotypic polymorphisms in carcinogen-metabolizing enzymes and cancer susceptibility].Nihon Rinsho. 1996 Aug;54(8):2261-75. Nihon Rinsho. 1996. PMID: 8810806 Review. Japanese.
-
Markers of genetic susceptibility in human environmental hygiene and toxicology: the role of selected CYP, NAT and GST genes.Int J Hyg Environ Health. 2003 Jun;206(3):149-71. doi: 10.1078/1438-4639-00209. Int J Hyg Environ Health. 2003. PMID: 12872524 Review.
-
Genotyping for polymorphisms in xenobiotic metabolism as a predictor of disease susceptibility.Environ Health Perspect. 1994 Nov;102 Suppl 9(Suppl 9):55-61. doi: 10.1289/ehp.94102s955. Environ Health Perspect. 1994. PMID: 7698086 Free PMC article.
-
Candidate genetic modifiers of individual susceptibility to renal cell carcinoma: a study of polymorphic human xenobiotic-metabolizing enzymes.Cancer Res. 1999 Jun 15;59(12):2903-8. Cancer Res. 1999. PMID: 10383153
-
Genetic polymorphisms in human xenobiotica metabolizing enzymes as susceptibility factors in toxic response.Mutat Res. 2000 Jan 3;464(1):65-76. doi: 10.1016/s1383-5718(99)00167-9. Mutat Res. 2000. PMID: 10633178 Review.
Cited by
-
Cervical cancer and CYP2E1 polymorphisms: implications for molecular epidemiology.Eur J Clin Pharmacol. 2006 Jan;62(1):15-21. doi: 10.1007/s00228-005-0066-y. Epub 2005 Dec 22. Eur J Clin Pharmacol. 2006. PMID: 16372174
-
Relationship among metabolizing genes, smoking and alcohol used as modifier factors on prostate cancer risk: exploring some gene-gene and gene-environment interactions.Eur J Epidemiol. 2005;20(1):79-88. doi: 10.1007/s10654-004-1632-9. Eur J Epidemiol. 2005. PMID: 15756908
-
Association of the GSTP1 and NQO1 polymorphisms and head and neck squamous cell carcinoma risk.J Korean Med Sci. 2006 Dec;21(6):1075-9. doi: 10.3346/jkms.2006.21.6.1075. J Korean Med Sci. 2006. PMID: 17179690 Free PMC article.
-
Smoking and polymorphisms in xenobiotic metabolism and DNA repair genes are additive risk factors affecting bladder cancer in Northern Tunisia.Pathol Oncol Res. 2011 Dec;17(4):879-86. doi: 10.1007/s12253-011-9398-3. Epub 2011 Jun 8. Pathol Oncol Res. 2011. PMID: 21647780
-
The association between methylene-tetrahydrofolate reductase gene polymorphism and lung cancer risk.Mol Biol Rep. 2011 Feb;38(2):991-6. doi: 10.1007/s11033-010-0194-z. Epub 2010 Jun 8. Mol Biol Rep. 2011. PMID: 20532637
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous